268 related articles for article (PubMed ID: 20950612)
21. Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease.
Halder RC; Aguilera C; Maricic I; Kumar V
J Clin Invest; 2007 Aug; 117(8):2302-12. PubMed ID: 17641782
[TBL] [Abstract][Full Text] [Related]
22. Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens.
Arrenberg P; Halder R; Kumar V
J Cell Physiol; 2009 Feb; 218(2):246-50. PubMed ID: 18814145
[TBL] [Abstract][Full Text] [Related]
23. Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor.
Patel O; Pellicci DG; Gras S; Sandoval-Romero ML; Uldrich AP; Mallevaey T; Clarke AJ; Le Nours J; Theodossis A; Cardell SL; Gapin L; Godfrey DI; Rossjohn J
Nat Immunol; 2012 Sep; 13(9):857-63. PubMed ID: 22820603
[TBL] [Abstract][Full Text] [Related]
24. Sulfatide inhibits α-galactosylceramide presentation by dendritic cells.
Kanamori M; Tasumi Y; Iyoda T; Ushida M; Inaba K
Int Immunol; 2012 Feb; 24(2):129-36. PubMed ID: 22247226
[TBL] [Abstract][Full Text] [Related]
25. Oral N-acetylcysteine decreases IFN-γ production and ameliorates ischemia-reperfusion injury in steatotic livers.
Liggett JR; Kang J; Ranjit S; Rodriguez O; Loh K; Patil D; Cui Y; Duttargi A; Nguyen S; He B; Lee Y; Oza K; Frank BS; Kwon D; Li HH; Kallakury B; Libby A; Levi M; Robson SC; Fishbein TM; Cui W; Albanese C; Khan K; Kroemer A
Front Immunol; 2022; 13():898799. PubMed ID: 36148239
[TBL] [Abstract][Full Text] [Related]
26. Sulfatide-activated type II NKT cells prevent allergic airway inflammation by inhibiting type I NKT cell function in a mouse model of asthma.
Zhang G; Nie H; Yang J; Ding X; Huang Y; Yu H; Li R; Yuan Z; Hu S
Am J Physiol Lung Cell Mol Physiol; 2011 Dec; 301(6):L975-84. PubMed ID: 21856813
[TBL] [Abstract][Full Text] [Related]
27. CD1d-Restricted Type II NKT Cells Reactive With Endogenous Hydrophobic Peptides.
Nishioka Y; Masuda S; Tomaru U; Ishizu A
Front Immunol; 2018; 9():548. PubMed ID: 29599785
[TBL] [Abstract][Full Text] [Related]
28. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
Teoh NC; Ito Y; Field J; Bethea NW; Amr D; McCuskey MK; McCuskey RS; Farrell GC; Allison AC
Gastroenterology; 2007 Aug; 133(2):632-46. PubMed ID: 17681182
[TBL] [Abstract][Full Text] [Related]
29. Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice.
Homma T; Kinugawa S; Takahashi M; Sobirin MA; Saito A; Fukushima A; Suga T; Takada S; Kadoguchi T; Masaki Y; Furihata T; Taniguchi M; Nakayama T; Ishimori N; Iwabuchi K; Tsutsui H
J Mol Cell Cardiol; 2013 Sep; 62():179-88. PubMed ID: 23774048
[TBL] [Abstract][Full Text] [Related]
30. Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.
Dasgupta S; Kumar V
Immunogenetics; 2016 Aug; 68(8):665-76. PubMed ID: 27405300
[TBL] [Abstract][Full Text] [Related]
31. Tumor necrosis factor-related apoptosis-inducing ligand on NK cells protects from hepatic ischemia-reperfusion injury.
Fahrner R; Trochsler M; Corazza N; Graubardt N; Keogh A; Candinas D; Brunner T; Stroka D; Beldi G
Transplantation; 2014 Jun; 97(11):1102-9. PubMed ID: 24804996
[TBL] [Abstract][Full Text] [Related]
32. Viral interleukin-10 gene transfer prevents liver ischemia-reperfusion injury: Toll-like receptor-4 and heme oxygenase-1 signaling in innate and adaptive immunity.
Ke B; Shen XD; Tsuchihashi S; Gao F; Araujo JA; Busuttil RW; Ritter T; Kupiec-Weglinski JW
Hum Gene Ther; 2007 Apr; 18(4):355-66. PubMed ID: 17439357
[TBL] [Abstract][Full Text] [Related]
33. Complexity and function of natural killer T cells with potential application to hepatic transplant survival.
Ware R; Kumar V
Liver Transpl; 2017 Dec; 23(12):1589-1592. PubMed ID: 28945950
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia-Inducible Factor-2α Limits Natural Killer T Cell Cytotoxicity in Renal Ischemia/Reperfusion Injury.
Zhang J; Han C; Dai H; Hou J; Dong Y; Cui X; Xu L; Zhang M; Xia Q
J Am Soc Nephrol; 2016 Jan; 27(1):92-106. PubMed ID: 25956511
[TBL] [Abstract][Full Text] [Related]
35. Natural killer T cell ligand alpha-galactosylceramide protects against gut ischemia reperfusion-induced organ injury in mice.
Zhang J; Bi J; Ren Y; Du Z; Li T; Li Q; Ke M; Dong J; Lv Y; Wu R
Cytokine; 2018 Nov; 111():237-245. PubMed ID: 30195979
[TBL] [Abstract][Full Text] [Related]
36. Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice.
Beldi G; Banz Y; Kroemer A; Sun X; Wu Y; Graubardt N; Rellstab A; Nowak M; Enjyoji K; Li X; Junger WG; Candinas D; Robson SC
Hepatology; 2010 May; 51(5):1702-11. PubMed ID: 20146261
[TBL] [Abstract][Full Text] [Related]
37. Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells.
Blomqvist M; Rhost S; Teneberg S; Löfbom L; Osterbye T; Brigl M; Månsson JE; Cardell SL
Eur J Immunol; 2009 Jul; 39(7):1726-35. PubMed ID: 19582739
[TBL] [Abstract][Full Text] [Related]
38. Beta-glucosylceramide administration (i.p.) activates natural killer T cells in vivo and prevents tumor metastasis in mice.
Inafuku M; Li C; Kanda Y; Kawamura T; Takeda K; Oku H; Watanabe H
Lipids; 2012 Jun; 47(6):581-91. PubMed ID: 22426862
[TBL] [Abstract][Full Text] [Related]
39. Autoreactivity to Sulfatide by Human Invariant NKT Cells.
Stax AM; Tuengel J; Girardi E; Kitano N; Allan LL; Liu V; Zheng D; Panenka WJ; Guillaume J; Wong CH; van Calenbergh S; Zajonc DM; van den Elzen P
J Immunol; 2017 Jul; 199(1):97-106. PubMed ID: 28526683
[TBL] [Abstract][Full Text] [Related]
40. Crosstalk between type II NKT cells and T cells leads to spontaneous chronic inflammatory liver disease.
Weng X; He Y; Visvabharathy L; Liao CM; Tan X; Balakumar A; Wang CR
J Hepatol; 2017 Oct; 67(4):791-800. PubMed ID: 28596110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]